CA2558783C - Formulation orale multiparticulaire de morphine - Google Patents

Formulation orale multiparticulaire de morphine Download PDF

Info

Publication number
CA2558783C
CA2558783C CA2558783A CA2558783A CA2558783C CA 2558783 C CA2558783 C CA 2558783C CA 2558783 A CA2558783 A CA 2558783A CA 2558783 A CA2558783 A CA 2558783A CA 2558783 C CA2558783 C CA 2558783C
Authority
CA
Canada
Prior art keywords
morphine
particle
beads
formulation
pareil seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2558783A
Other languages
English (en)
Other versions
CA2558783A1 (fr
Inventor
Paul Stark
Sean Cunningham
Jagathesan Moodley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Pharma Ireland Ltd
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/977,965 external-priority patent/US6066339A/en
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of CA2558783A1 publication Critical patent/CA2558783A1/fr
Application granted granted Critical
Publication of CA2558783C publication Critical patent/CA2558783C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

CA2558783A 1997-10-17 1997-12-05 Formulation orale multiparticulaire de morphine Expired - Lifetime CA2558783C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6252597P 1997-10-17 1997-10-17
US60/062,525 1997-10-17
US08/977,965 1997-11-25
US08/977,965 US6066339A (en) 1997-10-17 1997-11-25 Oral morphine multiparticulate formulation
CA002306333A CA2306333C (fr) 1997-10-17 1997-12-05 Formulation multiparticulaire de morphine orale

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002306333A Division CA2306333C (fr) 1997-10-17 1997-12-05 Formulation multiparticulaire de morphine orale

Publications (2)

Publication Number Publication Date
CA2558783A1 CA2558783A1 (fr) 1999-04-29
CA2558783C true CA2558783C (fr) 2013-01-22

Family

ID=37451511

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2558783A Expired - Lifetime CA2558783C (fr) 1997-10-17 1997-12-05 Formulation orale multiparticulaire de morphine

Country Status (1)

Country Link
CA (1) CA2558783C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111504928B (zh) * 2020-06-05 2023-06-16 深圳麦德凯诺医药科技有限公司 一种醋酸钙片溶出度的检测方法

Also Published As

Publication number Publication date
CA2558783A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
CA2306333C (fr) Formulation multiparticulaire de morphine orale
US6077533A (en) Powder-layered oral dosage forms
US5411745A (en) Powder-layered morphine sulfate formulations
US5002776A (en) Controlled absorption diltiazem formulations
US5616345A (en) Controlled absorption diltiazen formulation for once-daily administration
EP0377518B1 (fr) Composition pharmaceutique à libération retardée
CZ284382B6 (cs) Pevná léková forma s řízeným uvolňováním účinné látky
US20030161874A1 (en) Controlled release oral dosage form
EP1781275B1 (fr) Composition pharmaceutique de tolterodine a liberation prolongee
HU218673B (hu) Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
PL188919B1 (pl) Doustna, multijednostkowa kompozycja preparatu farmaceutycznego o modyfikowanym uwalnianiu oraz sposób wytwarzania jednostki dawkowania doustnej multijednostkowej kompozycji farmaceutycznej o modyfikowanym uwalnianiu
WO2003077867A2 (fr) Compositions a base de chlorhydrate de naltrexone
CS268819B2 (en) Method of particles production with effective substance's controlled loosening
HU206044B (en) Process for producing compositions with controlled release of dihydropyridine derivatives as active ingredient
WO2005032513A2 (fr) Preparations multiparticulaires de pantoprazole
EP0856313A1 (fr) Formulations de diltiazem à absorption contrÔlée
US7060293B1 (en) Powder-layered oral dosage forms
AU4426700A (en) Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
CA2558783C (fr) Formulation orale multiparticulaire de morphine
IE990406A1 (en) Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20171205